Dashboard M. tuberculosis
Repurposing candidates for M. tuberculosis
Mycobacterium tuberculosis
Approved medicines with AI-predicted activity ≥40% against M. tuberculosis, leaving out medicines that are already antimicrobials. Each is shown with what it is already used for. They are surfaced computationally for further investigation, not as treatments.
- AI-predicted activity ≥40%
- 1,072
- Existing antimicrobials set aside
- 128
- Needing review
- 74
- Repurposing candidates
- 870
Repurposing candidates for M. tuberculosis
AI prediction · nothing measuredAll 870 repurposing candidates for M. tuberculosis.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- InavolisibExisting use: Breast cancer, Breast neoplasm57.2% AI-predicted activityagainst M. tuberculosis36 registered studies
- RofecoxibExisting use: Rheumatic disease57.2% AI-predicted activityagainst M. tuberculosis32 registered studies
- Sildenafil CitrateExisting use: Connective tissue disease, Erectile dysfunction, Idiopathic and/or familial pulmonary arterial hypertension and 3 more57.2% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Rezafungin AcetateExisting use: Candidemia, Candidiasis, Candidiasis, Invasive57.2% AI-predicted activityagainst M. tuberculosis5 registered studies
- FamotidineExisting use: Chest pain, Duodenal ulcer, Dyspepsia and 7 more57.2% AI-predicted activityagainst M. tuberculosis50+ registered studies
- IdelalisibExisting use: Cancer, Chronic lymphocytic leukemia, Neoplasm and 2 more57.1% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Halofantrine HydrochlorideExisting use: Malaria57.1% AI-predicted activityagainst M. tuberculosis50+ registered studies
- TafluprostExisting use: Glaucoma, Ocular hypertension, Open-angle glaucoma57.1% AI-predicted activityagainst M. tuberculosis37 registered studies
- Spirapril HydrochlorideExisting use: Cardiovascular disease57.1% AI-predicted activityagainst M. tuberculosis3 registered studies
- Trametinib Dimethyl SulfoxideExisting use: Cancer, Cutaneous melanoma, Glioblastoma multiforme and 5 more57.0% AI-predicted activityagainst M. tuberculosis16 registered studies
- SincalideExisting use: Tests for bile duct patency57.0% AI-predicted activityagainst M. tuberculosis10 registered studies
- AprepitantExisting use: Cancer, Chemotherapy-induced nausea and vomiting, Nausea and 3 more57.0% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Galantamine HydrobromideExisting use: Alzheimer disease, Dementia57.0% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Acoramidis HydrochlorideExisting use: Amyloidosis, Cardiomyopathy, Male infertility56.9% AI-predicted activityagainst M. tuberculosis5 registered studies
- CabergolineExisting use: Hypothalamic neoplasm, Parkinson disease56.8% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Capmatinib HydrochlorideExisting use: Cancer, Neoplasm, Non-small cell lung carcinoma56.8% AI-predicted activityagainst M. tuberculosis3 registered studies
- Daclatasvir DihydrochlorideExisting use: Chronic hepatitis C virus infection, Viral disease56.8% AI-predicted activityagainst M. tuberculosis2 registered studies
- Dasabuvir SodiumExisting use: Chronic hepatitis C virus infection, Hepatitis C virus infection, Viral disease56.8% AI-predicted activityagainst M. tuberculosisNo documented evidence found
- Fosaprepitant DimeglumineExisting use: Cancer, Chemotherapy-induced nausea and vomiting, Nausea and 3 more56.8% AI-predicted activityagainst M. tuberculosis21 registered studies
- LifitegrastExisting use: Dry eye syndrome, Eye disease56.8% AI-predicted activityagainst M. tuberculosis39 registered studies
- OlaparibExisting use: Breast cancer, Breast carcinoma, Breast neoplasm and 9 more56.8% AI-predicted activityagainst M. tuberculosis50+ registered studies
- VoxelotorExisting use: Anemia, Anemia (phenotype), Sickle cell anemia56.8% AI-predicted activityagainst M. tuberculosis31 registered studies
- Zavegepant HydrochlorideExisting use: Migraine disorder56.8% AI-predicted activityagainst M. tuberculosisNo documented evidence found
- IvosidenibExisting use: Acute myeloid leukemia, Cholangiocarcinoma56.8% AI-predicted activityagainst M. tuberculosis50+ registered studies